Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Michael

Showing results (1171-1180 of 1,257) with videos related to

Pageof 126
Sort By:
American Heart Journal|January 20, 2021
Rationale and design of the CLEAR-outcomes trial: Evaluating the effect of bempedoic acid on cardiovascular events in patients with statin intoleranceStephenJ Nicholls, A Michael Lincoff, Harold E Bays, et al.
American Heart Journal|April 1, 2009
Rationale, design, and governance of Prospective Randomized Evaluation of Celecoxib Integrated Safety versus Ibuprofen Or Naproxen (PRECISION), a cardiovascular end point trial of nonsteroidal antiinflammatory agents in patients with arthritisMatthew C Becker, Thomas H Wang, Lisa Wisniewski, et al.
Nature Medicine|May 25, 2024
Long-term kidney outcomes of semaglutide in obesity and cardiovascular disease in the SELECT trialHelen M Colhoun, Ildiko Lingvay, Paul M Brown, et al.
Circulation|May 22, 2002
First experience with direct factor Xa inhibition in patients with stable coronary disease: a pharmacokinetic and pharmacodynamic evaluationChristopher K Dyke, Richard C Becker, Neal S Kleiman, et al.
Lancet (London, England)|March 21, 2007
Bivalirudin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a subgroup analysis from the Acute Catheterization and Urgent Intervention Triage strategy (ACUITY) trialGregg W Stone, Harvey D White, E Magnus Ohman, et al.
Clinical Endocrinology|April 28, 2011
UK guidance on the initial evaluation of an infant or an adolescent with a suspected disorder of sex developmentS Faisal Ahmed, John C Achermann, Wiebke Arlt, et al.
JAMA Network Open|December 27, 2023
Prostate Safety Events During Testosterone Replacement Therapy in Men With Hypogonadism: A Randomized Clinical TrialShalender Bhasin, Thomas G Travison, Karol M Pencina, et al.
Journal of the American Heart Association|June 23, 2026
Efficacy and Safety of Bempedoic Acid in Patients Aged ≥75 Years Stratified by Varying Statin Exposure: Results From Phase 3 Studies of Bempedoic AcidG B John Mancini, A Michael Lincoff, Anne C Goldberg, et al.
American Heart Journal|December 19, 2015
Assessment of the clinical effects of cholesteryl ester transfer protein inhibition with evacetrapib in patients at high-risk for vascular outcomes: Rationale and design of the ACCELERATE trialStephen J Nicholls, A Michael Lincoff, Philip J Barter, et al.
Vaccine|January 5, 2000
A phase I/II trial of HIV SF2 gp120/MF59 vaccine in seronegative thais.AFRIMS-RIHES Vaccine Evaluation Group. Armed Forces Research Institute of Medical Sciences and the Research Institute for Health SciencesS Nitayaphan, C Khamboonruang, N Sirisophana, et al.
Pageof 126

Showing results (1171-1180 of 1,257) with videos related to

Sort By:
Pageof 126
American Heart Journal|January 20, 2021
Rationale and design of the CLEAR-outcomes trial: Evaluating the effect of bempedoic acid on cardiovascular events in patients with statin intoleranceStephenJ Nicholls, A Michael Lincoff, Harold E Bays, et al.
American Heart Journal|April 1, 2009
Rationale, design, and governance of Prospective Randomized Evaluation of Celecoxib Integrated Safety versus Ibuprofen Or Naproxen (PRECISION), a cardiovascular end point trial of nonsteroidal antiinflammatory agents in patients with arthritisMatthew C Becker, Thomas H Wang, Lisa Wisniewski, et al.
Nature Medicine|May 25, 2024
Long-term kidney outcomes of semaglutide in obesity and cardiovascular disease in the SELECT trialHelen M Colhoun, Ildiko Lingvay, Paul M Brown, et al.
Circulation|May 22, 2002
First experience with direct factor Xa inhibition in patients with stable coronary disease: a pharmacokinetic and pharmacodynamic evaluationChristopher K Dyke, Richard C Becker, Neal S Kleiman, et al.
Lancet (London, England)|March 21, 2007
Bivalirudin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a subgroup analysis from the Acute Catheterization and Urgent Intervention Triage strategy (ACUITY) trialGregg W Stone, Harvey D White, E Magnus Ohman, et al.
Clinical Endocrinology|April 28, 2011
UK guidance on the initial evaluation of an infant or an adolescent with a suspected disorder of sex developmentS Faisal Ahmed, John C Achermann, Wiebke Arlt, et al.
JAMA Network Open|December 27, 2023
Prostate Safety Events During Testosterone Replacement Therapy in Men With Hypogonadism: A Randomized Clinical TrialShalender Bhasin, Thomas G Travison, Karol M Pencina, et al.
Journal of the American Heart Association|June 23, 2026
Efficacy and Safety of Bempedoic Acid in Patients Aged ≥75 Years Stratified by Varying Statin Exposure: Results From Phase 3 Studies of Bempedoic AcidG B John Mancini, A Michael Lincoff, Anne C Goldberg, et al.
American Heart Journal|December 19, 2015
Assessment of the clinical effects of cholesteryl ester transfer protein inhibition with evacetrapib in patients at high-risk for vascular outcomes: Rationale and design of the ACCELERATE trialStephen J Nicholls, A Michael Lincoff, Philip J Barter, et al.
Vaccine|January 5, 2000
A phase I/II trial of HIV SF2 gp120/MF59 vaccine in seronegative thais.AFRIMS-RIHES Vaccine Evaluation Group. Armed Forces Research Institute of Medical Sciences and the Research Institute for Health SciencesS Nitayaphan, C Khamboonruang, N Sirisophana, et al.
Pageof 126